Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | Gait as a differential marker of dementia disease subtype

Riona Mc Ardle • 9 Apr 2020
ARUK 2020
Dementia Dementia with Lewy Bodies

Riona Mc Ardle, PhD, Brain and Movement Research Group, Newcastle University, Newcastle upon Tyne, UK, outlines a study investigating if Alzheimer’s disease (AD) and Lewy body disease (LBD) have disease-specific gait impairments that may help differential diagnosis. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Riona Mc Ardle

1:35
Gait impairment and dementia
Riona Mc Ardle • 9 Apr 2020
1:36
Gait & dementia: tool to aid clinical decision-making and diagnosis
Riona Mc Ardle • 9 Apr 2020
1:07
Combining gait with other biomarkers for dementia
Riona Mc Ardle • 9 Apr 2020
1:02
The future landscape of biomarkers for dementia diagnosis
Riona Mc Ardle • 9 Apr 2020

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:31
Barriers to dementia treatment: awareness, accessibility, and affordability
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals